This funding will support Maisha Meds’ efforts to expand its mobile software platform to 7,500 pharmacies and clinics across Africa, providing subsidized malaria care to nearly 1 million patients.

Maisha Meds’ platform connects rural pharmacists and clinicians with affordable, quality medicines and provides them with incentives to follow best practices in malaria care.

The platform also offers discounted testing and treatment to patients, making it easier and more affordable for them to access essential healthcare services.

Stage 3 grants, DIV’s highest level of funding, are awarded to innovators who have demonstrated the ability to scale up their proven solutions to critical global challenges.

Maisha Meds has successfully used its platform to improve malaria care in Kenya and is now expanding its reach to other African countries.

In addition to the USAID DIV funding, Maisha Meds is also receiving support from the Bill & Melinda Gates Foundation.

This additional funding will help Maisha Meds to expand its reach and impact further.

About Maisha Meds

Maisha Meds is a leading digital health organization in Africa that provides affordable, high-quality healthcare services to rural communities.

The organization’s mobile software platform connects pharmacists and clinicians with affordable, quality medicines and provides them with incentives to follow best practices in malaria care.

Maisha Meds is also working to expand its platform to provide services for other health conditions, such as family planning and HIV prevention.